Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Novartis Pharmaceuticals
Current Parent Company: Novartis
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Penalty: $6,638,250
Year: 2012
Date: October 30, 2012
Offense Group: healthcare-related offenses
Primary Offense: off-label or unapproved promotion of medical products
Violation Description: The settlement resolved allegations of unlawfully marketing the eczema drug Elidel to treat infant children while failing to disclose the drug's known harmful side effects.
Level of Government: state
Action Type: agency action
Agency: Texas Attorney General
Civil or Criminal Case: civil
Facility State: Texas
HQ Country of Current Parent: Switzerland
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: Texas Attorney General's Office Secures $19.9 Million Agreement with Drug Maker Over Medicaid Fraud Allegations, Targeted News Service, October 30, 2012 (via Nexis).
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.